The addition of aPD-L1 enhances this effect, as evidenced by a further reduction in the proportions of myCAFs and ESM1+ ECs, thereby significantly limiting angiogenesis and affecting the oxygen supply to tumor cells. The gene discussed is ESM1; the disease is neoplasm.